Physician profile
Tonya E Bradley
NPI 1114990140
$4,911.49
in general payments reported to CMS, 2019-2025
43 companies · $745 in 2025
The $745 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $494 · 2021: $564 · 2022: $688 · 2023: $972 · 2024: $891 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $881.16 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Pfizer INC. | $481.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $277.89 | 2022-2025 | Arexvy, Shingrix |
| Corium, LLC | $241.36 | 2022-2024 | Azstarys |
| Neos Therapeutics, LP | $233.94 | 2019-2020 | |
| Allergan, INC. | $230.55 | 2019-2020 | |
| Lilly USA, LLC | $225.68 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Supernus Pharmaceuticals, INC. | $213.62 | 2019-2024 | Qelbree, Qelbree |
| Astrazeneca Pharmaceuticals LP | $186.81 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Tris Pharma INC | $159.49 | 2019-2024 | Dyanavel Xr |
| Novo Nordisk INC | $155.41 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Inspire Medical Systems, INC. | $154.47 | 2023-2024 | Inspire |
| Ironshore Pharmaceuticals INC. | $135.84 | 2022-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $117.40 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.22 | 2019-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.